These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 9364835)

  • 1. Current trends in onychomycosis therapy: a literature review.
    Hecker D
    Mt Sinai J Med; 1997 Nov; 64(6):399-405. PubMed ID: 9364835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The systemic treatment of onychomycosis.
    Wenig JA
    Clin Podiatr Med Surg; 1995 Apr; 12(2):263-74. PubMed ID: 7600500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The systemic treatment of onychomycosis.
    Wenig JA
    Clin Podiatr Med Surg; 2004 Oct; 21(4):579-89, vi. PubMed ID: 15450898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosis.
    Arca E; Taştan HB; Akar A; Kurumlu Z; Gür AR
    J Dermatolog Treat; 2002 Mar; 13(1):3-9. PubMed ID: 12006131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
    Gupta AK; Gregurek-Novak T
    Dermatology; 2001; 202(3):235-8. PubMed ID: 11385230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The new oral antifungal agents for onychomycosis of the toenails.
    Gupta AK; Shear NH
    J Eur Acad Dermatol Venereol; 1999 Jul; 13(1):1-13. PubMed ID: 10565624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis.
    Gupta AK; Ryder JE; Johnson AM
    Br J Dermatol; 2004 Mar; 150(3):537-44. PubMed ID: 15030339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of oral antifungal agents to treat onychomycosis.
    Gupta AK; Ryder JE
    Dermatol Clin; 2003 Jul; 21(3):469-79, vi. PubMed ID: 12956199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
    Gupta AK
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of fluconazole for the treatment of onychomycosis.
    Brown SJ
    Ann Pharmacother; 2009 Oct; 43(10):1684-91. PubMed ID: 19776299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cost/efficacy analysis of oral antifungals indicated for the treatment of onychomycosis: griseofulvin, itraconazole, and terbinafine.
    Angello JT; Voytovich RM; Jan SA
    Am J Manag Care; 1997 Mar; 3(3):443-50. PubMed ID: 10173095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New therapies for onychomycosis.
    Odom RB
    J Am Acad Dermatol; 1996 Sep; 35(3 Pt 2):S26-30. PubMed ID: 8784308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of systemic antimycotics in dermatotherapy.
    Niewerth M; Korting HC
    Eur J Dermatol; 2000 Mar; 10(2):155-60. PubMed ID: 10694319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacoeconomic analysis of oral antifungal therapies used to treat dermatophyte onychomycosis of the toenails. A US analysis.
    Gupta AK
    Pharmacoeconomics; 1998 Feb; 13(2):243-56. PubMed ID: 10178650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of onychomycosis in children.
    Gupta AK; De Rosso JQ
    Postgrad Med; 1999 Jul; Spec No():31-7. PubMed ID: 10492664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
    Gupta AK; Konnikov N; Lynde CW
    J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The safety of oral antifungal treatments for superficial dermatophytosis and onychomycosis: a meta-analysis.
    Chang CH; Young-Xu Y; Kurth T; Orav JE; Chan AK
    Am J Med; 2007 Sep; 120(9):791-8. PubMed ID: 17765049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Onychomycosis. Agents of choice.
    Hay RJ
    Dermatol Clin; 1993 Jan; 11(1):161-9. PubMed ID: 8382121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral therapy for onychomycosis: an evidence-based review.
    de Sá DC; Lamas AP; Tosti A
    Am J Clin Dermatol; 2014 Feb; 15(1):17-36. PubMed ID: 24352873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis.
    Gupta AK; Lynde CW; Konnikov N
    J Am Acad Dermatol; 2001 Mar; 44(3):485-91. PubMed ID: 11209119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.